Announcement on Voluntary Disclosure of Obtaining PIC/S GMP Certification
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Voluntary Disclosure of Obtaining PIC/S GMP Certification
Filed with SSE · · 2 pages · Chinese
Release
CanSino Biologics, Inc. on 6ix
Earlier from CanSino Biologics
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Obtaining the Supplementary Application Approval Notice for the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Carrier)
- CanSinoBIO at WGS 2026: Accelerating Global Access to Innovative Vaccines
- Announcement on Earnings Preannouncement for 2025
- Announcement on Obtaining Notice of Approval for Drug Clinical Trial for 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197, TT)
Later from CanSino Biologics
- Announcement on Requesting the General Meeting to Authorize the Board of Directors to Issue Shares to Specific Objects by Summary Procedure
- Announcement on Obtaining the Drug Registration Certificate for the Adsorbed Inactivated (Three-component) Diphtheria-Tetanus-Pertussis Vaccine for Infants and Young Children
- Announcement on Amending the "Articles of Association" and Its Attachments and Formulating the "Remuneration Management System for Directors and Senior Management Members"
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Voluntary Disclosure of Official Inclusion of the Adsorbed Acellular Pertussis (5-Component), Diphtheria and Tetanus Combined Vaccine (for People Aged 6 and Above) into the Priority Review List
Follow CanSino Biologics into a list and get an email when it puts out news.
Follow CanSino Biologics